Omada Health Inc Revenue Growth Rates (OMDA), Current and Historic Growth - CSIMarket
CSIMarket
 


Omada Health Inc   (NASDAQ: OMDA)
 

OMDA's Revenue Growth by Quarter and Year

Omada Health Inc 's Revenue results by quarter and year




OMDA Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 87.84
1st Quarter March 77.69
FY 165.52





OMDA Revenue second quarter 2026 Y/Y Growth Comment
Omada Health Inc achieved in the second quarter 2026, above Company average Revenue rise of 43.26% year on year, to $ 87.84 millions.

Looking into second quarter 2026 results within Medical Equipment & Supplies industry 30 other companies have achieved higher Revenue growth. While Omada Health Inc ' s Revenue jump of 43.26% ranks overall at the positon no. 529 in the second quarter 2026.




OMDA Revenue ( Y/Y Growth %) 2026
2025 2024 2023
4th Quarter December - -8.69 % - -
3rd Quarter September - 47.34 % - -
2nd Quarter June 43.26 % 48.77 % - -
1st Quarter March 41.36 % - - -
FY   - 52.64 % - -

Financial Statements
Omada Health Inc 's second quarter 2026 Revenue $ 87.84 millions OMDA's Income Statement
Omada Health Inc 's second quarter 2025 Revenue $ 61.31 millions Quarterly OMDA's Income Statement


OMDA Revenue (Quarter on Quarter Growth %)

2026
2025 2024 2023
4th Quarter December - 13.09 % 82.49 % -
3rd Quarter September - 9.39 % 10.46 % -
2nd Quarter June 13.06 % 11.55 % - -
1st Quarter March 2.43 % -33.84 % - -
FY (Year on Year)   - 52.64 % - -




Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #31
Healthcare Sector #125
Overall #529

Revenue Y/Y Growth Statistics
High Average Low
48.76 % 34.41 % -8.7 %
(Mar 31 2026)  
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #31
Healthcare Sector #125
Overall #529
Revenue Y/Y Growth Statistics
High Average Low
48.76 % 34.41 % -8.7 %
(Mar 31 2026)  

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Omada Health Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
95.03 % 18.44 % -40.61 %
(Dec 31 2025)  


OMDA's II. Quarter Q/Q Revenue Comment
Omada Health Inc achieved in the II. Quarter 2026 below company average Revenue rise of 13.06% quarter on quarter, to $ 87.84 millions.

II. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the 11.55% in the II. Quarter a year ago.

Within Medical Equipment & Supplies industry 29 other companies have achieved higher Revenue quarter on quarter growth. While Omada Health Inc 's Revenue growth quarter on quarter, overall rank is 701.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #30
Healthcare Sector #118
Overall #701
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #30
Healthcare Sector #118
Overall #701
Revenue Q/Q Growth Statistics
High Average Low
95.03 % 18.44 % -40.61 %
(Dec 31 2025)  


OMDA's II. Quarter Q/Q Revenue Comment
Omada Health Inc achieved in the II. Quarter 2026 below company average Revenue rise of 13.06% quarter on quarter, to $ 87.84 millions.

II. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the 11.55% in the II. Quarter a year ago.

Within Medical Equipment & Supplies industry 29 other companies have achieved higher Revenue quarter on quarter growth. While Omada Health Inc 's Revenue growth quarter on quarter, overall rank is 701.


Omada Health Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)
12 Months Ending
(Mar 31 2026)
12 Months Ending
(Dec 31 2025)
12 Months Ending
(Sep 30 2025)
12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 308.44 $ 281.92 $ 259.19 $ 0.00 $ 61.31
Y / Y Revenue Growth (TTM) 25.97 % 25.43 % - - -
Year on Year Revenue Growth Overall Ranking # 303 # 292 # 0 # 0 # 0
Seqeuential Revenue Change (TTM) 9.41 % 8.77 % -2.71 % - -
Seq. Revenue Growth (TTM) Overall Ranking # 680 # # # #


Cumulative Revenue growth Comment
Although Omada Health Inc 's Annual Revenue growth year on year were below company's average 49.88% , Revenue announced in the Jun 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 25.97% year on year, from 25.43% in Mar 31 2026.

In the Healthcare sector 87 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 292 to 303.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 56
Healthcare Sector # 88
Overall # 303

Revenue TTM Y/Y Growth Statistics
High Average Low
49.88 %
49.88 %
49.88 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 147
Sector # 404
S&P 500 # 2876
Cumulative Revenue growth Comment
Although Omada Health Inc 's Annual Revenue growth year on year were below company's average 49.88% , Revenue announced in the Jun 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 25.97% year on year, from 25.43% in Mar 31 2026.

In the Healthcare sector 87 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 292 to 303.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 56
Healthcare Sector # 88
Overall # 303

Revenue TTM Y/Y Growth Statistics
High Average Low
49.88 %
49.88 %
49.88 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 147
Sector # 404
S&P 500 # 2876




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
OMDA's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue rise for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Innovative Eyewear Inc 74.46%$ 74.459 millions
Madrigal Pharmaceuticals Inc 71.17%$ 71.169 millions
Tg Therapeutics Inc 70.27%$ 70.272 millions
Tarsus Pharmaceuticals Inc 69.41%$ 69.406 millions
Hyperfine Inc 67.70%$ 67.698 millions
Alnylam Pharmaceuticals Inc 66.86%$ 66.856 millions
Emergent Biosolutions Inc 66.29%$ 66.288 millions
Vivos Therapeutics Inc 65.69%$ 65.691 millions
Iovance Biotherapeutics inc 65.65%$ 65.654 millions
Billiontoone Inc 64.40%$ 64.403 millions
Anteris Technologies Global Corp 63.27%$ 63.269 millions
Nexgel Inc 63.24%$ 63.242 millions
Carlsmed Inc 59.58%$ 59.575 millions
Sonoma Pharmaceuticals Inc 59.55%$ 59.552 millions
Arcutis Biotherapeutics Inc 59.33%$ 59.331 millions
Nephros Inc 58.55%$ 58.551 millions
Bioadaptives Inc 54.95%$ 54.955 millions
Zevra Therapeutics Inc 53.25%$ 53.251 millions
Beyond Air Inc 52.94%$ 52.941 millions
Caredx Inc 52.23%$ 52.226 millions
Bioxcel Therapeutics Inc 51.67%$ 51.667 millions
Glaukos Corp50.63%$ 50.628 millions
Heartflow Inc 49.80%$ 49.801 millions
Coya Therapeutics Inc 48.97%$ 48.974 millions
Travere Therapeutics Inc 48.17%$ 48.174 millions
Halozyme Therapeutics Inc 47.67%$ 47.673 millions
Eli Lilly And Company47.67%$ 47.670 millions
Rhythm Pharmaceuticals Inc 46.91%$ 46.911 millions
Axsome Therapeutics Inc 45.54%$ 45.543 millions
Guardant Health Inc 44.33%$ 44.332 millions


About Omada Health Inc Revenue Growth Rates (OMDA), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Omada Health Inc (CIK 1611115).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001628280-26-054840
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Omada Health Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.